Johnson & Johnson & Ethicon Transvaginal Mesh Case — Update

Johnson & Johnson & Ethicon Transvaginal Mesh Case — Update

In April of 2018, an Indiana jury found Johnson & Johnson and Ethicon, a subsidiary of Johnson & Johnson, liable to Barbara Kaiser, an Indiana native, for injuries sustained after Barbara was implanted with the Prolift transvaginal mesh, a product of Johnson & Johnson, and experienced severe discomfort, pain, and injuries. Aside from such discomfort and pain, she specifically experienced “permanent injury that required corrective surgery after her doctor implanted her” with the transvaginal mesh.

A transvaginal mesh, or pelvic mesh, is an implant used to treat pelvic organ prolapse and stress urinary incontinence in women.

The jury found Johnson & Johnson and Ethicon to be negligent in the design and marketing (misleading the general public about the risks involved) of the pelvic mesh and found them liable for $10 million in compensatory damages and $25 million in punitive damages. An Indiana federal judge brought down the punitive damages amount to $10 million. Barbara Kaiser will receive $20 million in compensatory and punitive damages.

Barbara, and her husband Anton, sought the expert legal help of Thomas O. Plouff, (Of Counsel to Costello, McMahon, Burke & Murphy, LTD, Chicago)  Plouff stated:

Ethicon defended an indefensible product and the jury stood up for Barb Kaiser. We thank them for their service.  We are thrilled to help a remarkable woman  who suffered at the hands of a corporation who put profits over patient safety.


Related Posts

Stryker Accolade hip implants

Stryker Accolade implant revision patients report high blood metal levels with LFIT cobalt femoral heads. Mismatched implant metals can cause metallosis and dislocations requiring painful revision surgery. Over 500,000 patients…
Read more

Bard ALIGN transvaginal mesh…

New Jersey based C. R. Bard is a worldwide creator and distributor of medical products. Founded in 1907 by Charles R. Bard, the company specializes in creating surgical, vascular, oncology,…
Read more